Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-positive bacterial cytoplasmic membrane is a vital phospholipid bilayer that serves as the primary barrier between the bacterial cytoplasm and the external environment [Strahl & Hamoen, 2010]. It plays a critical role in maintaining cellular homeostasis, facilitating nutrient transport, and hosting essential processes such as oxidative phosphorylation and the synthesis of the peptidoglycan cell wall [Heidary et al., 2022]. In Gram-positive bacteria, this membrane is characterized by a high content of negatively charged phospholipids like phosphatidylglycerol, which makes it a selective target for cationic antimicrobial peptides and lipopeptide antibiotics [Zhanel et al., 2010]. Drugs like daptomycin interact with this membrane in a calcium-dependent manner to cause rapid depolarization and ion leakage, leading to bacterial cell death without requiring entry into the cytoplasm [Heidary et al., 2022]. Because this structure is fundamental to bacterial viability and differs significantly in lipid composition from eukaryotic membranes, it remains a key target for treating multi-drug resistant infections such as methicillin-resistant Staphylococcus aureus (MRSA) [StatPearls, 2023]. However, therapeutic use of membrane-targeting drugs requires monitoring for systemic toxicities, such as elevations in creatine phosphokinase indicative of muscle damage [StatPearls, 2023].
Drugs targeting the Gram-positive cytoplasmic membrane typically act by binding to membrane components such as phosphatidylglycerol or Lipid II, leading to membrane depolarization, pore formation, and the leakage of intracellular ions like potassium [Heidary et al., 2022]. This disruption of the membrane potential halts macromolecular synthesis and results in rapid bactericidal activity [Strahl & Hamoen, 2010].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-positive bacterial cytoplasmic membrane.